HK1011369A1 - Alkali metal 8.9- dehyddroestrone sulfate esters - Google Patents

Alkali metal 8.9- dehyddroestrone sulfate esters

Info

Publication number
HK1011369A1
HK1011369A1 HK98112284A HK98112284A HK1011369A1 HK 1011369 A1 HK1011369 A1 HK 1011369A1 HK 98112284 A HK98112284 A HK 98112284A HK 98112284 A HK98112284 A HK 98112284A HK 1011369 A1 HK1011369 A1 HK 1011369A1
Authority
HK
Hong Kong
Prior art keywords
dehyddroestrone
alkali metal
sulfate esters
esters
sulfate
Prior art date
Application number
HK98112284A
Other languages
English (en)
Inventor
Panolil Chrukand Raveendranath
John Anthony Wichtowski
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Priority to HK99105414A priority Critical patent/HK1020282A1/xx
Publication of HK1011369A1 publication Critical patent/HK1011369A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Catalysts (AREA)
HK98112284A 1992-02-26 1998-11-24 Alkali metal 8.9- dehyddroestrone sulfate esters HK1011369A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HK99105414A HK1020282A1 (en) 1992-02-26 1998-11-24 Alkali metal 8,9-dehydroestrone sulfate esters

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/841,694 US5210081A (en) 1992-02-26 1992-02-26 Alkali metal 8,9-dehydroestrone sulfate esters
PCT/US1993/001500 WO1993017036A1 (en) 1992-02-26 1993-02-19 Alkali metal 8,9-dehydroestrone sulfate esters

Publications (1)

Publication Number Publication Date
HK1011369A1 true HK1011369A1 (en) 1999-07-09

Family

ID=25285489

Family Applications (2)

Application Number Title Priority Date Filing Date
HK99105414A HK1020282A1 (en) 1992-02-26 1998-11-24 Alkali metal 8,9-dehydroestrone sulfate esters
HK98112284A HK1011369A1 (en) 1992-02-26 1998-11-24 Alkali metal 8.9- dehyddroestrone sulfate esters

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK99105414A HK1020282A1 (en) 1992-02-26 1998-11-24 Alkali metal 8,9-dehydroestrone sulfate esters

Country Status (22)

Country Link
US (3) US5210081A (de)
EP (2) EP0628052B1 (de)
JP (1) JP3715645B2 (de)
KR (1) KR100256861B1 (de)
AR (2) AR042262A2 (de)
AT (2) ATE174342T1 (de)
AU (2) AU677181B2 (de)
CA (1) CA2089707A1 (de)
DE (2) DE69322497T2 (de)
DK (2) DK0628052T3 (de)
ES (2) ES2125975T3 (de)
FI (1) FI115915B (de)
GR (1) GR3029620T3 (de)
HK (2) HK1020282A1 (de)
HU (2) HUT67553A (de)
LV (1) LV12240B (de)
MX (1) MX9300969A (de)
PT (1) PT864583E (de)
SG (1) SG49715A1 (de)
TW (1) TW257677B (de)
WO (1) WO1993017036A1 (de)
ZA (1) ZA93746B (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210081A (en) * 1992-02-26 1993-05-11 American Home Products Corporation Alkali metal 8,9-dehydroestrone sulfate esters
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
DE4334823C2 (de) * 1993-10-09 1998-09-17 Schering Ag Verfahren zur Herstellung von Schwefelsäurehalbestern von Estrogenen
US5395831A (en) * 1994-04-08 1995-03-07 American Home Products Corporation Treating cardiac disorders with Δ9(11)-dehydro-8-isoestrone
US5861431A (en) * 1995-06-07 1999-01-19 Iotek, Inc. Incontinence treatment
US5998639A (en) * 1995-11-06 1999-12-07 Akzo Nobel, N.V. Sulfatation of estrogen mixtures
AU703814B2 (en) * 1995-12-04 1999-04-01 Wyeth Antioxidant
DE19631542C1 (de) * 1996-07-25 1997-08-28 Schering Ag Verfahren zur Herstellung von 3-Sulfatoxy-estra-1,3,5(10)-trien-Derivaten II
DE19631543C1 (de) * 1996-07-25 1997-11-20 Schering Ag Verfahren zur Herstellung von 3-Sulfatoxy-estra-1,3,5(10)-trien-Derivaten I
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
ID18256A (id) * 1996-09-16 1998-03-19 American Home Prod Penggunaan dari 8,9-dehidro estron sebagai estrogen dengan hasil netral pada tingkat prolaktin
AR014096A1 (es) * 1996-10-11 2001-02-07 Wyeth Corp 17 alfa,8,9-deshidroestradiol y 17 beta delta 8,9 deshidroestradiol, el uso de los mismos para la manufactura de un medicamento, una composicionfarmaceutica que los comprende y un procedimiento para su preparacion.
ZA979204B (en) * 1996-10-16 1999-04-14 American Home Prod Use of 8,9-dehydroestrone in treating vasomotor symptoms
IL124213A (en) * 1997-05-02 2004-12-15 Akzo Nobel Nv Sulfation of estrogen mixtures
US6432643B1 (en) 1999-10-22 2002-08-13 Duke University Method of determining Alzheimer's disease risk using apolipoprotein E4 genotype analysis in combination with decreased estrogen levels
US7989436B2 (en) 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US6660726B2 (en) 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US6855703B1 (en) * 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20030158432A1 (en) * 2002-01-08 2003-08-21 Leonard Thomas W. Synthesis of a mixture of sulfated estrogens using a sulfur trioxide complex
US8349819B2 (en) * 2002-10-09 2013-01-08 Dr. Reddy's Laboratories New York, Inc. Steroid extraction process from urine sources
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
JP2006522833A (ja) * 2003-04-11 2006-10-05 バー・ラボラトリーズ，インコーポレイテッド エストロゲンおよびプロゲスチンの投与法
AR049142A1 (es) * 2004-06-07 2006-06-28 Wyeth Corp Composiciones para recubrimientos de azucar,composiciones recubiertas y metodos para la fabricacion de los mismos
US20060040904A1 (en) * 2004-08-17 2006-02-23 Ahmed Salah U Vaginal cream compositions, kits thereof and methods of using thereof
EP1853272A1 (de) * 2005-02-03 2007-11-14 Duramed Pharmaceuticals, Inc. Zusammensetzungen aus unkonjugierten östrogenen und anwendungsverfahren dafür
AU2006263638A1 (en) * 2005-06-29 2007-01-04 Wyeth Formulations of conjugated estrogens and bazedoxifene
US8217024B2 (en) * 2005-12-27 2012-07-10 Teva Women's Health, Inc. Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof
JP2010509350A (ja) * 2006-11-07 2010-03-25 ワイス エルエルシー 糖コーティングおよびその方法
KR20090104862A (ko) * 2007-01-12 2009-10-06 와이어쓰 정제내 정제 조성물
WO2008100769A2 (en) * 2007-02-09 2008-08-21 Wyeth Process for selective sulfation of aromatic hydroxyl groups
US7902147B2 (en) * 2007-11-05 2011-03-08 Duke University Chronic lymphocytic leukemia prognosis and treatment
TW201127386A (en) 2009-10-27 2011-08-16 Wyeth Llc Bazedoxifene formulations with antioxidants

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2834712A (en) * 1953-05-27 1958-05-13 American Home Prod Urinary estrogen compositions and methods for preparing them
US3079410A (en) * 1960-04-02 1963-02-26 Hoechst Ag Process for stabilizing anionic and cationic ester salts of 21-hydroxy-20-ketosteroids in an aqueous solution
US3959322A (en) * 1960-09-22 1976-05-25 Herchel Smith Synthesis of 13-alkyl-gon-4-ones
DE1200476B (de) * 1961-04-10 1965-09-09 Frosst & Co Charles E Stabilisierung von trockenen Zubereitungen synthetischer Alkalisalze von OEstronsulfat
US3551459A (en) * 1962-10-04 1970-12-29 Herchel Smith 13-methyl-8-isogonanes
US3394153A (en) * 1965-08-18 1968-07-23 Merck & Co Inc Process for the preparation of d, 1-8-dehydroestrone, and intermediates obtained therefrom
NL6805153A (de) * 1968-04-10 1969-10-14
US3644618A (en) * 1968-10-29 1972-02-22 Frosst & Co Charles E Stable composition of synthetic sodium estrone sulfate
US3608077A (en) * 1969-11-13 1971-09-21 Syntex Corp Stabilization of metal steroid alcohol sulfates
US3649621A (en) * 1969-12-19 1972-03-14 American Home Prod Novel 3-cyclopentyl ethers of 13-alkylgon-poly-enes
GB1451109A (en) * 1973-08-17 1976-09-29 Rech Et Dapplications Scient S Derivatives of oestrone and their use in therapy
GB1528321A (en) * 1975-07-07 1978-10-11 Leo Ab Acylation process for the preparation of phenolic n,n-di-substituted carbamate esters
SE439586B (sv) * 1975-09-05 1985-06-24 Kanebo Ltd Sett att framstella ett stabilt farmaceutiskt torrpreparat av ett alkalimetallsalt av dehydroepiandrosteronsulfat
US4154820A (en) * 1976-02-23 1979-05-15 Akzona Incorporated Compositions containing alkali metal sulfate salts of conjugated estrogens and antioxidants as stabilizers
US5210081A (en) * 1992-02-26 1993-05-11 American Home Products Corporation Alkali metal 8,9-dehydroestrone sulfate esters

Also Published As

Publication number Publication date
ATE174342T1 (de) 1998-12-15
FI943903A0 (fi) 1994-08-25
DE69322497T2 (de) 1999-05-06
PT864583E (pt) 2007-01-31
AR042262A2 (es) 2005-06-15
AR042345A2 (es) 2005-06-15
DK0628052T3 (da) 1999-07-12
EP0864583A3 (de) 2004-07-21
JPH07504197A (ja) 1995-05-11
GR3029620T3 (en) 1999-06-30
CA2089707A1 (en) 1993-08-27
US6169082B1 (en) 2001-01-02
DE69334073D1 (de) 2006-11-23
FI943903A (fi) 1994-08-25
TW257677B (de) 1995-09-21
SG49715A1 (en) 1998-06-15
AU711571B2 (en) 1999-10-14
WO1993017036A1 (en) 1993-09-02
HK1020282A1 (en) 2000-04-07
LV12240A (lv) 1999-03-20
HU211971A9 (en) 1996-01-29
ES2274555T3 (es) 2007-05-16
KR100256861B1 (ko) 2000-08-01
EP0864583B1 (de) 2006-10-11
DK0864583T3 (da) 2006-12-04
ZA93746B (en) 1994-08-03
EP0864583A2 (de) 1998-09-16
US5288717A (en) 1994-02-22
KR950700318A (ko) 1995-01-16
AU3726093A (en) 1993-09-13
MX9300969A (es) 1993-09-01
EP0628052A1 (de) 1994-12-14
US5210081A (en) 1993-05-11
HUT67553A (en) 1995-04-28
AU677181B2 (en) 1997-04-17
HU9402457D0 (en) 1994-10-28
JP3715645B2 (ja) 2005-11-09
FI115915B (fi) 2005-08-15
LV12240B (en) 1999-06-20
EP0628052B1 (de) 1998-12-09
ES2125975T3 (es) 1999-03-16
DE69322497D1 (de) 1999-01-21
ATE342272T1 (de) 2006-11-15
DE69334073T2 (de) 2007-02-01
AU2007697A (en) 1997-07-03

Similar Documents

Publication Publication Date Title
HK1011369A1 (en) Alkali metal 8.9- dehyddroestrone sulfate esters
GB2290537B (en) Alkali metal dispersions
GB2267783B (en) Beam forming
GB9223932D0 (en) Metal accumulation
ZA931772B (en) Imidazolyl-substituted phenylacetamides.
GB9425873D0 (en) Metal structures
GB9221842D0 (en) Lance
EP0571732A3 (de) Metall-Schmelzofen.
GB9218762D0 (en) Esters
GB9205701D0 (en) Surfactant
AU121576S (en) Metal section
GB9227076D0 (en) Metal structures
PL54232Y1 (en) Metal shape
AU108934S (en) Metal section
AU108932S (en) Metal section
AU108936S (en) Metal section
AU108938S (en) Metal section
AU108935S (en) Metal section
AU108939S (en) Metal section
AU115016S (en) Metal section
GB9204696D0 (en) Paladin 1
ZA926636B (en) Metal cabinet.
AU117717S (en) Pull out shelf assembly
GB9206621D0 (en) G.t.l. ex 1
GB9204036D0 (en) The"secura-grip"

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20080219